{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:40:07Z","timestamp":1745642407826,"version":"3.40.4"},"reference-count":17,"publisher":"Japanese Urological Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2024,4,20]]},"DOI":"10.5980\/jpnjurol.115.94","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T22:07:16Z","timestamp":1745100436000},"page":"94-98","source":"Crossref","is-referenced-by-count":0,"title":["A CASE OF CARCINOSARCOMA OF THE RETROPERITONEUM: A CASE REPORT","\u5f8c\u8179\u819c\u8154\u306b\u767a\u751f\u3057\u305f\u764c\u8089\u816b\u306e\u4e00\u4f8b"],"prefix":"10.5980","volume":"115","author":[{"given":"Yu","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Urology, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Urology, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Urology, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[{"name":"Department of Urology, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Otsuki A, Watanabe Y, Nomura H, Futagami M, Yokoyama Y, Shibata K, Kamoi K, Arakawa A, Nishiyama H, Katsuta T, Kudaka W, Shimada M, Sato N, Kotera K, Katabuchi H and Yaegashi N: Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit. Int J Gynecol Cancer., 25, 92-97, 2015.","DOI":"10.1097\/IGC.0000000000000302"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Barker HE and Scott CL: Genomics of gynaecological carcinosarcomas and future treatment options. Semin Cancer Biol., 61, 110-120, 2020.","DOI":"10.1016\/j.semcancer.2019.10.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Xu F, Huang Y and Yang J: Primary retroperitoneal carcinosarcoma in a child: a case report. World J Surg Oncol., 8, 99, 2010.","DOI":"10.1186\/1477-7819-8-99"},{"key":"4","unstructured":"4) Ferrie RK and Ross RC: Ross: Retroperitoneal M\u00fcllerian carcinosarcoma. Can Med Assoc J., 97, 1290-1292, 1967."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shintaku M and Matsumoto T: Primary mullerian carcinosarcoma of the retroperitoneum: report of a case. Int J Gynecol Pathol., 20, 191-195, 2001.","DOI":"10.1097\/00004347-200104000-00013"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Booth C, Zahn CM, McBroom J and Maxwell GL: Retroperitoneal m\u00fcllerian carcinosarcoma associated with endometriosis: a case report. Gynecol Oncol., 93, 546-549, 2004.","DOI":"10.1016\/j.ygyno.2004.01.018"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Herman CW and Tessler AN: Extragenital mixed heterologous tumor of mullerian origin arising in retroperitoneum. Urology., 22, 49-50, 1983.","DOI":"10.1016\/0090-4295(83)90346-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sparks D, Chase D, Forsyth M, Ghani A and Segall G: A rare case of primary extragenital retroperitoneal carcinosarcoma with review of the literature. Gynecol Surg., 7, 259-262, 2010.","DOI":"10.1007\/s10397-008-0461-3"},{"key":"9","unstructured":"9) \u4e00\u7bad\u73e0\u8cb4, \u91ce\u6751\u660c\u53f2, \u4e09\u4e95\u614e\u4e5f, \u5fd7\u7530\u52c7\u4eba, \u99d2\u5834\u798f\u96c4, \u91d1 \u4fca\u6587, \u77e2\u6839 \u572d, \u677e\u5c45\u525b\u5fd7, \u897f\u68ee\u535a\u5e78, \u8fbb \u90a6\u5f66, \u59dc \u8c9e\u61b2, \u5c0f\u5c71\u5185\u5b66, \u6f5f\u6cbc\u6717\u751f, \u9ad8\u6a4b\u90a6\u5e78, \u771f\u53e3\u5b8f\u4ecb, \u7be0\u539f\u654f\u4e5f, \u6e05\u6c34 \u5eb7, \u79cb\u7530\u5f18\u4fca: \u5f8c\u8179\u819c\u539f\u767a\u7c98\u6db2\u6027\u56a2\u80de\u817a\u764c\u306e1\u4f8b-\u672c\u90a6\u5831\u544a\u4f8b\u306e\u96c6\u8a08\u3092\u542b\u3081\u3066-. \u65e5\u81e8\u5916\u4f1a\u8a8c, 106, 826-833, 2009."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Park S and Kim HS: Primary Retroperitoneal Mucinous Carcinoma with Carcinosarcomatous Mural Nodules: A Case Report with Emphasis on Its Histological Features and Immunophenotype. Diagnostics (Basel)., 10, 580, 2020.","DOI":"10.3390\/diagnostics10080580"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Homesley HD, Filiaci V, Markman M, Bitterman P, Eaton L, Kilgore LC, Monk BJ and Ueland FR; Gynecologic Oncology Group: Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol., 25, 526-531, 2007.","DOI":"10.1200\/JCO.2006.06.4907"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hoskins PJ, Le N, Ellard S, Lee U, Martin LA, Swenerton KD and Tinker AV: Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Gynecol Oncol., 108, 58-62, 2008.","DOI":"10.1016\/j.ygyno.2007.08.084"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ardighieri L, Mori L, Conzadori S, Bugatti M, Falchetti M, Donzelli CM, Ravaggi A, Odicino FE and Facchetti F: Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship. Virchows Arch., 469, 61-69, 2016.","DOI":"10.1007\/s00428-016-1933-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilg\u00fcvar K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP and Santin AD: Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A., 113, 12238-12243, 2016.","DOI":"10.1073\/pnas.1614120113"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Arend RC, Goel N, Roane BM, Foxall ME, Dholakia J, Londo\u00f1o AI, Wall JA, Leath CA 3rd and Huh WK: Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study. Gynecol Oncol., 163, 85-92, 2021.","DOI":"10.1016\/j.ygyno.2021.07.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gotoh O, Sugiyama Y, Takazawa Y, Kato K, Tanaka N, Omatsu K, Takeshima N, Nomura H, Hasegawa K, Fujiwara K, Taki M, Matsumura N, Noda T and Mori S: Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma. Nat Commun., 10, 4965, 2019.","DOI":"10.1038\/s41467-019-12985-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Bhangoo MS, Boasberg P, Mehta P, Elvin JA, Ali SM, Wu W and Klempner SJ: Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE- Mutant Uterine Carcinosarcoma. Oncologist., 23, 518-523, 2018.","DOI":"10.1634\/theoncologist.2017-0342"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/115\/2\/115_94\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:05:27Z","timestamp":1745640327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/115\/2\/115_94\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.115.94","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"type":"print","value":"0021-5287"},{"type":"electronic","value":"1884-7110"}],"subject":[],"published":{"date-parts":[[2024,4,20]]}}}